Integra Lifesciences Holdings (IART) Current Deferred Tax Assets (2009 - 2015)

Integra Lifesciences Holdings has disclosed Current Deferred Tax Assets across 7 years of filings, most recently posting $46.9 million for Q3 2015.

• In Q3 2015, Current Deferred Tax Assets rose 5.92% year-over-year to $46.9 million; the TTM figure through Sep 2015 stood at $46.9 million (up 5.92% YoY), while the FY2014 annual figure was $30.6 million, down 37.13% from the prior year.
• Current Deferred Tax Assets came in at $46.9 million for Q3 2015 at Integra Lifesciences Holdings, down from $58.2 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $64.6 million in Q3 2012 to a low of $30.6 million in Q4 2014.
• Average Current Deferred Tax Assets over 5 years is $44.6 million, with a median of $40.0 million recorded in 2013.
• Year-over-year, Current Deferred Tax Assets soared 77.53% in 2012 and sank 38.78% in 2013.
• Over 5 years, Current Deferred Tax Assets stood at $36.2 million in 2011, then advanced by 8.15% to $39.1 million in 2012, then grew by 24.34% to $48.6 million in 2013, then slumped by 37.13% to $30.6 million in 2014, then surged by 53.44% to $46.9 million in 2015.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $46.9 million in Q3 2015, $58.2 million in Q2 2015, and $58.3 million in Q1 2015.